DZ2905A1 - Nouveaux composés dérivés d'ureidopipéridine, ant agonistes sélectifs des récepteurs nk3 humains, procédé pour leur obtention et compositions pharmaceutiques les contenant. - Google Patents
Nouveaux composés dérivés d'ureidopipéridine, ant agonistes sélectifs des récepteurs nk3 humains, procédé pour leur obtention et compositions pharmaceutiques les contenant.Info
- Publication number
- DZ2905A1 DZ2905A1 DZ990205A DZ990205A DZ2905A1 DZ 2905 A1 DZ2905 A1 DZ 2905A1 DZ 990205 A DZ990205 A DZ 990205A DZ 990205 A DZ990205 A DZ 990205A DZ 2905 A1 DZ2905 A1 DZ 2905A1
- Authority
- DZ
- Algeria
- Prior art keywords
- ureidopiperidine
- receptors
- human
- production
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9812859A FR2784377B3 (fr) | 1998-10-09 | 1998-10-09 | Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DZ2905A1 true DZ2905A1 (fr) | 2004-03-01 |
Family
ID=9531536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DZ990205A DZ2905A1 (fr) | 1998-10-09 | 1999-10-06 | Nouveaux composés dérivés d'ureidopipéridine, ant agonistes sélectifs des récepteurs nk3 humains, procédé pour leur obtention et compositions pharmaceutiques les contenant. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6465489B1 (ru) |
| EP (1) | EP1119552A1 (ru) |
| JP (1) | JP2002527423A (ru) |
| KR (1) | KR20010085903A (ru) |
| CN (1) | CN1133622C (ru) |
| AR (1) | AR029148A1 (ru) |
| AU (1) | AU751592B2 (ru) |
| BR (1) | BR9914397A (ru) |
| CA (1) | CA2346729A1 (ru) |
| CO (1) | CO5180555A1 (ru) |
| DZ (1) | DZ2905A1 (ru) |
| EA (1) | EA003613B1 (ru) |
| EE (1) | EE200100214A (ru) |
| FR (1) | FR2784377B3 (ru) |
| HU (1) | HUP0201709A3 (ru) |
| IL (1) | IL142362A0 (ru) |
| IS (1) | IS5897A (ru) |
| NO (1) | NO20011779L (ru) |
| NZ (1) | NZ510779A (ru) |
| PL (1) | PL347910A1 (ru) |
| SK (1) | SK4642001A3 (ru) |
| TR (1) | TR200101030T2 (ru) |
| TW (1) | TW539669B (ru) |
| WO (1) | WO2000021931A1 (ru) |
| YU (1) | YU26001A (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001068604A2 (en) | 2000-03-14 | 2001-09-20 | Sepracor, Inc. | 3-substituted piperidines comprising urea functionality, and methods of use thereof |
| WO2004005256A2 (en) * | 2002-07-03 | 2004-01-15 | Glaxo Group Limited | Substituted 4-phenyl-piperidin-amides as tachykinin antagonists and serotonin reptake inhibitors |
| US20110144081A1 (en) | 2009-12-15 | 2011-06-16 | Henner Knust | Pyrrolidine derivatives |
| US9554659B2 (en) | 2012-10-22 | 2017-01-31 | Uwm Research Foundation, Inc. | Infant sleep pod |
| JPWO2020101017A1 (ja) * | 2018-11-15 | 2021-09-30 | 国立大学法人九州大学 | Ｉｌ−３１介在性疾患の予防又は治療剤及び医薬組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL99320A (en) | 1990-09-05 | 1995-07-31 | Sanofi Sa | Arylalkylamines, their preparation and pharmaceutical preparations containing them |
| FR2676055B1 (fr) | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
| FR2688219B1 (fr) | 1992-03-03 | 1994-07-08 | Sanofi Elf | Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant. |
| FR2719311B1 (fr) * | 1994-03-18 | 1998-06-26 | Sanofi Sa | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. |
| FR2738819B1 (fr) | 1995-09-14 | 1997-12-05 | Sanofi Sa | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
| AU4176997A (en) * | 1996-09-16 | 1998-04-02 | Warner-Lambert Company | 3-alkyl-3-phenyl-piperidines |
-
1998
- 1998-10-09 FR FR9812859A patent/FR2784377B3/fr not_active Expired - Lifetime
-
1999
- 1999-10-04 TR TR2001/01030T patent/TR200101030T2/xx unknown
- 1999-10-04 CN CNB998142085A patent/CN1133622C/zh not_active Expired - Fee Related
- 1999-10-04 EE EEP200100214A patent/EE200100214A/xx unknown
- 1999-10-04 NZ NZ510779A patent/NZ510779A/en unknown
- 1999-10-04 JP JP2000575840A patent/JP2002527423A/ja active Pending
- 1999-10-04 EP EP99970379A patent/EP1119552A1/fr not_active Withdrawn
- 1999-10-04 SK SK464-2001A patent/SK4642001A3/sk unknown
- 1999-10-04 PL PL99347910A patent/PL347910A1/xx not_active Application Discontinuation
- 1999-10-04 WO PCT/FR1999/002355 patent/WO2000021931A1/fr not_active Application Discontinuation
- 1999-10-04 CA CA002346729A patent/CA2346729A1/en not_active Abandoned
- 1999-10-04 YU YU26001A patent/YU26001A/sh unknown
- 1999-10-04 AU AU59887/99A patent/AU751592B2/en not_active Ceased
- 1999-10-04 KR KR1020017004456A patent/KR20010085903A/ko not_active Application Discontinuation
- 1999-10-04 BR BR9914397-6A patent/BR9914397A/pt not_active IP Right Cessation
- 1999-10-04 IL IL14236299A patent/IL142362A0/xx unknown
- 1999-10-04 HU HU0201709A patent/HUP0201709A3/hu unknown
- 1999-10-04 US US09/806,878 patent/US6465489B1/en not_active Expired - Fee Related
- 1999-10-04 EA EA200100299A patent/EA003613B1/ru not_active IP Right Cessation
- 1999-10-05 TW TW088117155A patent/TW539669B/zh not_active IP Right Cessation
- 1999-10-06 DZ DZ990205A patent/DZ2905A1/xx active
- 1999-10-07 AR ARP990105081A patent/AR029148A1/es not_active Application Discontinuation
- 1999-10-08 CO CO99064055A patent/CO5180555A1/es not_active Application Discontinuation
-
2001
- 2001-03-16 IS IS5897A patent/IS5897A/is unknown
- 2001-04-06 NO NO20011779A patent/NO20011779L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU751592B2 (en) | 2002-08-22 |
| US6465489B1 (en) | 2002-10-15 |
| PL347910A1 (en) | 2002-04-22 |
| IL142362A0 (en) | 2002-03-10 |
| CA2346729A1 (en) | 2000-04-20 |
| NO20011779L (no) | 2001-06-07 |
| HUP0201709A2 (en) | 2002-09-28 |
| FR2784377B3 (fr) | 2000-11-17 |
| FR2784377A1 (fr) | 2000-04-14 |
| KR20010085903A (ko) | 2001-09-07 |
| AR029148A1 (es) | 2003-06-18 |
| BR9914397A (pt) | 2001-06-26 |
| EA003613B1 (ru) | 2003-06-26 |
| EA200100299A1 (ru) | 2001-10-22 |
| JP2002527423A (ja) | 2002-08-27 |
| CN1329594A (zh) | 2002-01-02 |
| SK4642001A3 (en) | 2001-09-11 |
| NO20011779D0 (no) | 2001-04-06 |
| AU5988799A (en) | 2000-05-01 |
| WO2000021931A1 (fr) | 2000-04-20 |
| HUP0201709A3 (en) | 2003-03-28 |
| IS5897A (is) | 2001-03-16 |
| NZ510779A (en) | 2003-07-25 |
| TR200101030T2 (tr) | 2001-08-21 |
| EE200100214A (et) | 2002-08-15 |
| CN1133622C (zh) | 2004-01-07 |
| CO5180555A1 (es) | 2002-07-30 |
| YU26001A (sh) | 2003-04-30 |
| TW539669B (en) | 2003-07-01 |
| EP1119552A1 (fr) | 2001-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DZ2128A1 (fr) | Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2962A1 (fr) | Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant. | |
| FR2718136B1 (fr) | Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant. | |
| DZ2729A1 (fr) | Composés nouveaux inhibiteurs de nhe-1 procédé pour leur préparation et compositions pharmaceutiquesles contenant. | |
| DZ2891A1 (fr) | Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| CY2537B1 (fr) | Composés hétérocycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| DZ3052A1 (fr) | Composés nouveaux inhibiteurs de métalloprotéases,procédé pour leur préparation et compositions pha rmaceutiques les contenant. | |
| DZ2753A1 (fr) | Hydroxamides d'acides (4-arylsulfonylamino)-tétrahydropyranne-4-carboxyliques) procédé pour leur préparation et compositions les contenant. | |
| MA26659A1 (fr) | Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. | |
| DZ2890A1 (fr) | 4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2963A1 (fr) | Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2889A1 (fr) | 4-Carboxyamino-2-méthyl-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositionspharmaceutiques les contenant. | |
| DZ3038A1 (fr) | Modulateurs nouveaux des récepteurs de glucocorticoïdes, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2217A1 (fr) | Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant. | |
| DZ3042A1 (fr) | Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ1889A1 (fr) | Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| MA26551A1 (fr) | Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
| DZ2866A1 (fr) | 1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2300A1 (fr) | Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2299A1 (fr) | Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ2045A1 (fr) | Amides thérapeutiques, procédé pour leur préparation et compositions les contenant. | |
| MA26686A1 (fr) | Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
| MA24484A1 (fr) | Atropisomeres de 3-aryl-4(3h)-quinazolinones, procede pour leur preparation et compositions les contenant . | |
| DZ1957A1 (fr) | Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
| DZ3045A1 (fr) | Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. |